This review highlights CMR relaxometry with T1 mapping as an emerging, accurate, and quantitative technique for assessing diffuse myocardial fibrosis.
CMR imaging has been widely used to assess myocardial perfusion and scar, and is the noninvasive gold standard for identification of focal myocardial fibrosis. However the LGE technique is limited in its accuracy for absolute quantification and assessment of diffuse myocardial fibrosis by technical and pathophysiological features. CMR Relaxometry, incorporating T1 mapping, has emerged as an accurate, reproducible, highly sensitive and quantitative technique for the assessment of diffuse myocardial fibrosis in a number of disease states. We comprehensively review detailed physics and development behind CMR relaxometry, the evidence base, and the clinical applications of this emerging technique.
Hamilton‐Craig et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: